Skip to main content

Table 3 The sensitivity and specificity of the model in the estimation and validation group

From: A newly noninvasive model for prediction of non-alcoholic fatty liver disease: utility of serum prolactin levels

 Cut-offEstimation groupValidation group
non NAFLDNAFLDSensitivity (%)Specificity (%)AUC (95%CI)non NAFLDNAFLDSensitivity (%)Specificity (%)AUC (95%CI)
Male> − 0.794611895.955.30.87 (0.83–0.92)4611995.254.50.86 (0.82–0.91)
<−0.79575556
> 1.7156351.295.196451.291.1
< 1.7198609261
Female> − 0.682610494.5740.91 (0.87–0.96)4110297.161.30.82 (0.76–0.88)
<−0.68746653
> 2.1635751.89755234.091.4
< 2.16975353101
  1. NAFLD Non-alcoholic fatty liver disease, AUC Area under the ROC curve
\